| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/13/2011 | EP2307354A1 Process for preparing a benzoylbenzeneacetamide derivative |
| 04/13/2011 | EP2307046A2 Thrombopoietic activity of tyrosyl-trna synthetase polypeptides |
| 04/13/2011 | EP2306999A2 Compositions for treating rosacea |
| 04/13/2011 | EP2306828A1 Prolyl hydroxylase inhibitors |
| 04/13/2011 | EP1896466B1 N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 04/13/2011 | EP1542978B1 Novel bio-active molecules |
| 04/13/2011 | EP1539763B1 Azaindole kinase inhibitors |
| 04/13/2011 | CN1823088B Novel peptides that bind to the erythropoietin receptor |
| 04/13/2011 | CN102015685A Substituted dihydropyrazolones as inhibitors of HIF-prolyl-4-hydroxylases |
| 04/13/2011 | CN102014921A Composition for modulating stem cell growth with prostaglandins |
| 04/13/2011 | CN102010424A Crystal form III of (S)-alpha, alpha-[(2-chlorphenyl)-(4,5,6,7-thiophane[3,2-c]pyridine-5-yl)-N'-(dimethyl)methylene] acethydrazide and preparation method thereof |
| 04/13/2011 | CN102010423A Crystal form II of (S)-alpha, alpha-[(2-chlorphenyl)-(4,5,6,7-tetrahydrothieno [3,2-c] pyridine-5-yl)]-N'-(dimethyl) methylene) acethydrazide and preparation method |
| 04/13/2011 | CN102010324A Aspirin-triggered lipid mediators |
| 04/13/2011 | CN102010298A Indene derivatives as pharmaceutical agents |
| 04/13/2011 | CN102008741A Anti-inflammation and tissue regeneration-promoting sanitary towel and manufacturing method thereof |
| 04/13/2011 | CN102008731A Preparation method of fluorocarbon nanometer medicine-carrying preparation using block copolymer as carrier |
| 04/13/2011 | CN102008727A Injection-purpose medicine composition for improving stability of ligustrazine medicine injection formulation and preparation method of injection-purpose medicine composition |
| 04/13/2011 | CN102008658A Traditional Chinese medicine capsule for curing cerebral thrombosis |
| 04/13/2011 | CN102008631A Composition of safflower oil and garlic extract and application thereof |
| 04/13/2011 | CN102008558A Application of thalictrum foeniculaceum extract in preparation of medicaments for treating blood diseases |
| 04/13/2011 | CN102008554A Chinese medicinal mixture for treating upper gastrointestinal bleeding |
| 04/13/2011 | CN102008541A Method for simultaneously detecting three main active ingredients in sugar-free type compound wintercreeper preparation |
| 04/13/2011 | CN102008528A Compound sea cucumber preparation and preparation method thereof |
| 04/13/2011 | CN102008520A Drug for preventing and treating chronic mountain sickness and preparation method thereof |
| 04/13/2011 | CN102008509A Maixuekang enteric coated tablets and preparation method thereof |
| 04/13/2011 | CN102008506A Formula of injection for convergence and hemostasis of internal hemorrhoid hemorrhage and preparation method thereof |
| 04/13/2011 | CN102008504A Blood plasma product for clinical transfusion and preparation method thereof |
| 04/13/2011 | CN102008503A Hematopoietic cells from human embryonic stem cells |
| 04/13/2011 | CN102008500A Medicinal external emulsifiable paste for relieving pain and itching and subsiding swelling |
| 04/13/2011 | CN102008498A Application of pseudo-ginsenoside GQ |
| 04/13/2011 | CN102008442A Preparation method of fluorocarbon vesicle medicament carrying preparation |
| 04/13/2011 | CN101757599B Medicinal granules comprising brown sugar, Colla corii Asini, Cornu cervi Pantotrichum, ginseng, clove, costus root, red jujube and tea |
| 04/13/2011 | CN101627968B Preparation method of alprostadil injection |
| 04/13/2011 | CN101611061B Recombinant chimeric protein of neutrophil inhibitory factor and hirugen and medicament composition thereof |
| 04/13/2011 | CN101554379B Pharmaceutical composition containing clopidogrel |
| 04/13/2011 | CN101554377B Pharmaceutical composition containing prasugrel and carbazochrome sodium sulfonate |
| 04/13/2011 | CN101461804B (+)-1-(3,4-dichlorrophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 04/13/2011 | CN101456864B Prasugrel sulphate, composition and method for making the same |
| 04/13/2011 | CN101444496B Compounds for the treatment of metabolic disorders |
| 04/13/2011 | CN101396525B Traditional Chinese medicine preparation for treating cerebrovascular disease |
| 04/13/2011 | CN101322803B Hemostatic and anti-inflammation powder |
| 04/13/2011 | CN101288680B Preparation method of instant tuckahoe granule |
| 04/13/2011 | CN101284029B Pain relieving, hemostasia and antipruritic drug powder |
| 04/13/2011 | CN101283997B Application of bromine phenolic compound in preparing the medicine for curing the ischemic cardio-vascular and cerebrovascular diseases |
| 04/13/2011 | CN101267823B Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects |
| 04/13/2011 | CN101239095B Method for preparing embolism-extinguishing enteric-coated capsule |
| 04/13/2011 | CN101199752B Oral administration Chinese medicine for treating haemostasis retained hematemesis |
| 04/13/2011 | CN101199548B Perfluorination carbon emulsion and preparing method thereof |
| 04/13/2011 | CN101185737B Orally-administered traditional Chinese medicine for treating stomach-heat type hematemesis |
| 04/13/2011 | CN101115709B Aminocarboxylic acid derivative and medicinal use thereof |
| 04/13/2011 | CN101095751B Medicinal composition having functions of removing chloasma and improving nutritional anemia and method for preparing the same |
| 04/12/2011 | US7923436 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 04/12/2011 | US7923431 Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
| 04/12/2011 | CA2526771C Synthesis of high molecular weight iron-saccharidic complexes |
| 04/12/2011 | CA2491398C Processes for preparing triethanolamine salts of low molecular weight heparin and their use in topical creams for antithrombotic therapy |
| 04/12/2011 | CA2400908C Fusion protein having enhanced in vivo erythropoietin activity |
| 04/12/2011 | CA2387107C Derivatives of dicarboxylic acid having pharmaceutical properties |
| 04/12/2011 | CA1341612C Human tissue plasminogen activator variants and processes |
| 04/07/2011 | WO2011040565A1 Anti-podoplanin antibody, and pharmaceutical composition containing anti-podoplanin antibody |
| 04/07/2011 | WO2011040449A1 Novel phenol derivative |
| 04/07/2011 | WO2011038537A1 Methods and kits for the prediction, prevention and treatment of septicemia and septic shock |
| 04/07/2011 | WO2010149172A3 SYSTEMIC PRO-HEMOSTATIC EFFECT OF CLOTTING FACTORS IN COMBINATION WITH SYMPATHICOMIMETICS WITH AGONISTIC EFFECTS ON α-ADRENERGIC AND/OR β-ADRENERGIC RECEPTORS OF THE SYMPATHETIC NERVOUS SYSTEM, RELATED TO IMPROVED CLOT STRENGTH. |
| 04/07/2011 | US20110082206 Heteroatom containing substituted fatty acids |
| 04/07/2011 | US20110082194 Synergistic Anticoagulant Composition |
| 04/07/2011 | US20110082177 N'-nitroxyalkylnicotinamides for the treatment of cardiovascular diseases |
| 04/07/2011 | US20110082110 Water-soluble benzoazepine compound and its pharmaceutical composition |
| 04/07/2011 | US20110082083 Formulations of liquid stable antithrombin |
| 04/07/2011 | US20110081409 Selective inhibitors of histone deacetylase |
| 04/07/2011 | US20110081371 Angiotensin peptide-carrier conjugates and uses thereof |
| 04/07/2011 | US20110081361 Antibodies that bind interleukin-4 receptor |
| 04/07/2011 | US20110081334 C1-Inhibitor Prevents Non-Specific Plasminogen Activation by a Prourokinase Mutant without Impeding Fibrin-Specific Fibrinolysis |
| 04/07/2011 | US20110081312 3'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 04/07/2011 | CA2776503A1 Compositions and methods for enhancing coagulation factor viii function |
| 04/07/2011 | CA2775309A1 Novel phenol derivative |
| 04/06/2011 | EP2305804A1 MonoPEGylated human growth hormone |
| 04/06/2011 | EP2305802A1 Modified vitamin K-dependent polypeptides |
| 04/06/2011 | EP2305795A1 Method of collecting placental stem cells |
| 04/06/2011 | EP2305713A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305712A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305684A1 Poycyloalkylpurines as adenosine receptor antagonists |
| 04/06/2011 | EP2305677A1 Alkyne-aryl-naphthyridin-4(1h)-one derivatives as type IV phosphodiesterase inhibitor |
| 04/06/2011 | EP2305663A1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF alpha levels |
| 04/06/2011 | EP2305653A1 Therapeutic agent for chronic renal failure |
| 04/06/2011 | EP2305314A2 Remodelling and glycoconjugation of antibodies |
| 04/06/2011 | EP2305313A2 Remodelling and glycoconjugation of interferon-alpha (IFNa) |
| 04/06/2011 | EP2305312A2 Remodelling and glycoconjugation of follicle-stimulating hormone (FSH) |
| 04/06/2011 | EP2305311A2 Glycoconjugation of peptides |
| 04/06/2011 | EP2305289A1 Medicinal products for the treatment of blood coagulation disorders |
| 04/06/2011 | EP2305248A1 Substituted phenethylsulfones and method of reducing tnf-alpha levels |
| 04/06/2011 | EP2305233A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/06/2011 | EP2305232A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/06/2011 | EP2305231A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/06/2011 | EP2304023A2 Platelet fraction deriving from placental blood |
| 04/06/2011 | EP2303917A2 Antagonists of actriib and uses for increasing red blood cell levels |
| 04/06/2011 | EP2303849A1 Substituted quinazolines |
| 04/06/2011 | EP2303307A2 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
| 04/06/2011 | EP2303289A1 Mono ( iron hydroxypyrone ) and combination ( iron hydroxypyrone and gi inflammation inhibiting agents ) compositions for anaemia or h. pylori infections |
| 04/06/2011 | EP2303278A1 Composition for modulating stem cell growth with prostaglandins |
| 04/06/2011 | EP2303243A1 Oral composition containing an anti-plaque agent of the thienopyridine family in the form of a base |
| 04/06/2011 | EP1628968B1 4-imidazolin-2-one compounds |